Site name unknown - Moscow

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST)	Terminated	Closed	Nilotinib or Imatinib	NCT00751036
2	Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) (IMAGE) (Novartis CSTI571BIC08)	Completed	Closed	Imatinib	NCT01172548